Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4901 USD | -0.59% | -8.15% | -6.18% |
May. 10 | Earnings Flash (KPRX) KIORA PHARMACEUTICALS Posts Q1 Revenue $16M | MT |
Mar. 25 | Kiora Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Kiora Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Kiora Pharmaceuticals, Inc.
HC Wainwright | |
Maxim | |
Ladenburg Thalmann | |
Alliance Global Partners |
EPS Revisions
- Stock Market
- Equities
- KPRX Stock
- Consensus Kiora Pharmaceuticals, Inc.